* Eikon search string for individual stock moves: STXBZ
* The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
U.S. stock index futures rose on Wednesday after remarks from Federal Reserve
officials helped calm inflation worries, while a recent dip in bond yields
supported Nasdaq futures climb for a third straight session. .N
At 6:55 ET, Dow e-minis 1YMc1 were up 0.23% at 34,350. S&P 500 e-minis
ESc1 were up 0.29% at 4,197.5, while Nasdaq 100 e-minis NQc1 were up 0.30%
at 13,697.75.
The top three NYSE percentage gainers premarket .PRPG.NQ :
** RYB Education Inc RYB , up 9.2%
** DoubleVerify Holdings Inc DV , up 8.4%
** Renesola Ltd SOL , up 7.8%
The top three NYSE percentage losers premarket .PRPL.NQ :
** China Green Agriculture Inc CGA , down 18%
** Build-A-Bear Workshop Inc BBW , down 17.2%
** GSX Techedu Inc GOTU.K , down 15.9%
The top three Nasdaq percentage gainers premarket .PRPG.O :
** Nabriva Therapeutics Plc NBRV.O , up 62.2%
** Aequi Acquisition Corp ARBGW.O , up 25.5%
** Pieris Pharmaceuticals Inc PIRS.O , up 24.2%
The top three Nasdaq percentage losers premarket .PRPL.O :
** Larimar Therapeutics Inc LRMR.O , down 37.8%
** Lixiang Education Holding Co Ltd LXEH.O , down 15.9%
** Professional Diversity Network Inc IPDN.O , down 13.5%
** GSX Techedu GOTU.N : down 15.9% premarket
Slumps to 1-1/2-year low on Q1 loss urn:newsml:reuters.com:*:nL3N2ND2ND
** Lipocine LPCN.O : down 8.0% premarket
Drops as Clarus Therapeutics wins patent infringement lawsuit urn:newsml:reuters.com:*:nL3N2ND2MS
** Nabriva Therapeutics NBRV.O : up 62.2% premarket
Surges as pneumonia drug meets main goal in China urn:newsml:reuters.com:*:nL3N2ND2M6
** Riot Blockchain RIOT.O : up 5.4% premarket
** Marathon Digital Holdings MARA.O : up 3.3% premarket
** Coinbase Global COIN.O : up 1.6% premarket
** MicroStrategy Inc MSTR.O : up 3.3% premarket
Crypto stocks up as bitcoin crosses $40,000 again urn:newsml:reuters.com:*:nL3N2ND2IV
** Pieris Pharmaceuticals PIRS.O : up 24.2% premarket
Soars as co's stock draws retail traders' interest urn:newsml:reuters.com:*:nL3N2ND2JC
** Larimar Therapeutics Inc LRMR.O : down 37.8% premarket
Larimar slumps as FDA puts hold on neuromuscular disorder drug trial
urn:newsml:reuters.com:*:nL3N2ND2HO
(Compiled by Chavi Mehta in Bengaluru)